|
1
|
Charalampakis N, Economopoulou P,
Kotsantis I, Tolia M, Schizas D, Liakakos T, Elimova E, Ajani JA
and Psyrri A: Medical management of gastric cancer: A 2017 update.
Cancer Med. 7:123–133. 2018. View Article : Google Scholar :
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
3
|
Tabuchi S: The autotaxin-lysophosphatidic
acid-lysophosphatidic acid receptor cascade: Proposal of a novel
potential therapeutic target for treating glioblastoma multiforme.
Lipids Health Dis. 14:562015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mills GB and Moolenaar WH: The emerging
role of lysophosphatidic acid in cancer. Nat Rev Cancer. 3:582–591.
2003. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kihara Y, Maceyka M, Spiegel S and Chun J:
Lysophospholipid receptor nomenclature review: IUPHAR review 8. Br
J Pharmacol. 171:3575–3594. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee SC, Fujiwara Y, Liu J, Yue J, Shimizu
Y, Norman DD, Wang Y, Tsukahara R, Szabo E, Patil R, et al:
Autotaxin and LPA1 and LPA5 receptors exert disparate functions in
tumor cells versus the host tissue microenvironment in melanoma
invasion and metastasis. Mol Cancer Res. 13:174–185. 2015.
View Article : Google Scholar
|
|
7
|
Li M, Xiao D, Zhang J, Qu H, Yang Y, Yan
Y, Liu X, Wang J, Liu L, Wang J and Duan X: Expression of LPA2 is
associated with poor prognosis in human breast cancer and regulates
HIF-1α expression and breast cancer cell growth. Oncol Rep.
36:3479–3487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Enooku K, Uranbileg B, Ikeda H, Kurano M,
Sato M, Kudo H, Maki H, Koike K, Hasegawa K, Kokudo N and Yatomi Y:
Higher LPA2 and LPA6 mRNA levels in hepatocellular carcinoma are
associated with poorer differentiation, microvascular invasion and
earlier recurrence with higher serum autotaxin levels. PLoS One.
11:e01618252016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yun CC, Sun H, Wang D, Rusovici R,
Castleberry A, Hall RA and Shim H: LPA2 receptor mediates mitogenic
signals in human colon cancer cells. Am J Physiol Cell Physiol.
289:C2–C11. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mukherjee A, Ma Y, Yuan F, Gong Y, Fang Z,
Mohamed EM, Berrios E, Shao H and Fang X: Lysophosphatidic acid
up-regulates hexokinase II and glycolysis to promote proliferation
of ovarian cancer cells. Neoplasia. 17:723–734. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang R, Wang J, Ma S, Huang Z and Zhang
G: Requirement of Osteopontin in the migration and protection
against Taxol-induced apoptosis via the ATX-LPA axis in SGC7901
cells. BMC Cell Biol. 12:112011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Venkatraman G, Benesch MG, Tang X, Dewald
J, McMullen TP and Brindley DN: Lysophosphatidate signaling
stabilizes Nrf2 and increases the expression of genes involved in
drug resistance and oxidative stress responses: Implications for
cancer treatment. FASEB J. 29:772–785. 2015. View Article : Google Scholar
|
|
13
|
Yamashita H, Kitayama J, Shida D, Ishikawa
M, Hama K, Aoki J, Arai H and Nagawa H: Differential expression of
lysophosphatidic acid receptor-2 in intestinal and diffuse type
gastric cancer. J Surg Oncol. 93:30–35. 2006. View Article : Google Scholar
|
|
14
|
Gu C, Wang F, Zhao Z, Wang H, Cong X and
Chen X: Lysophosphatidic acid is associated with atherosclerotic
plaque instability by regulating NF-κB dependent matrix
metallopro-teinase-9 expression via LPA2 in macrophages.
Front Physiol. 8:2662017. View Article : Google Scholar
|
|
15
|
Dang TP: Notch, apoptosis and cancer. Adv
Exp Med Biol. 727:199–209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu YY, Zheng MH, Zhang R, Liang YM and Han
H: Notch signaling pathway and cancer metastasis. Adv Exp Med Biol.
727:186–198. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rizzo P, Osipo C, Foreman K, Golde T,
Osborne B and Miele L: Rational targeting of Notch signaling in
cancer. Oncogene. 27:5124–5131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamamoto S, Schulze KL and Bellen HJ:
Introduction to Notch signaling. Methods Mol Biol. 1187:1–14. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuan Q, Chen X, Han Y, Lei T, Wu Q, Yu X,
Wang L, Fan Z and Wang S: Modification of α2,6-sialylation mediates
the invasiveness and tumorigenicity of non-small cell lung cancer
cells in vitro and in vivo via Notch1/Hes1/MMPs pathway. Int J
Cancer. 143:2319–2330. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei G, Chang Y, Zheng J, He S, Chen N,
Wang X and Sun X: Notch1 silencing inhibits proliferation and
invasion in SGC7901 gastric cancer cells. Mol Med Rep. 9:1153–1158.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang H, Wang X, Xu J and Sun Y: Notch1
activation is a poor prognostic factor in patients with gastric
cancer. Br J Cancer. 110:2283–2290. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu XX, Hu Z, Shen X, Dong LY, Zhou WZ and
Hu WH: IL- 33 p romotes gastric cancer cell invasion and migration
Via ST2 ERK1/2 p athway. Dig Dis Sci. 60:1265–1272. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Liu S, Yan J, Peng L, Chen M, Yang J
and Zhang G: The characteristics, prognosis, and risk factors of
lymph node metastasis in early gastric cancer. Gastroenterol Res
Pract. 2018:69457432018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Song Q, Ji Q and Li Q: The role and
mechanism of β-arrestins in cancer invasion and metastasis
(Review). Int J Mol Med. 41:631–639. 2018.
|
|
25
|
Tian D, Li Y, Li X and Tian Z: Aloperine
inhibits proliferation, migration and invasion and induces
apoptosis by blocking the Ras signaling pathway in human breast
cancer cells. Mol Med Rep. 18:3699–3710. 2018.PubMed/NCBI
|
|
26
|
Osborne CC, Perry KJ, Shankland M and
Henry JQ: Ectomesoderm and EMT-related genes in spiralian
development. Dev Dyn. 247:2018.Doi: 1002/dvdy.24667. View Article : Google Scholar
|
|
27
|
Nantajit D, Lin D and Li JJ: The network
of epithelial-mesen-chymal transition: Potential new targets for
tumor resistance. J Cancer Res Clin Oncol. 141:1697–1713. 2015.
View Article : Google Scholar
|
|
28
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Z, He J, Xing X, Li P, Zhang W, Tong
Z, Jing X, Li L, Liu D, Wu Q and Ju H: Mn12Ac inhibits the
migration, invasion and epithelial-mesenchymal transition of lung
cancer cells by downregulating the Wnt/β-catenin and PI3K/AKT
signaling pathways. Oncol Lett. 16:3943–3948. 2018.PubMed/NCBI
|
|
30
|
Zhao L, Pang A and Li Y: Function of GCN5
in the TGF-β1-induced epithelial-to-mesenchymal transition in
breast cancer. Oncol Lett. 16:3955–3963. 2018.PubMed/NCBI
|
|
31
|
Linna MA, Chen Z, Zhi-Heng R, Xiao Z and
Xu Z: Expression of LPA2 regulates the migration, invasion,
proliferation, and apoptosis of gastric cancer SGC-7901 cells. Sci
Technol Eng. 18:26–32. 2018.
|
|
32
|
Liu X, Sun K, Song A, Zhang X, Zhang X and
He X: Curcumin inhibits proliferation of gastric cancer cells by
impairing ATP-sensitive potassium channel opening. World J Surg
Oncol. 12:3892014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhu Z, Wang G, Yang F, Cao W, Mao R, Du X,
Zhang X, Li C, Li D, Zhang K, et al: Foot-and-mouth disease virus
viroporin 2B antagonizes RIG-I-mediated antiviral effects by
inhibition of its protein expression. J Virol. 90:11106–11121.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Arranz-Valsero I, Soriano-Romaní L,
García-Posadas L, López-García A and Diebold Y: IL-6 as a corneal
wound healing mediator in an in vitro scratch assay. Exp Eye Res.
125:183–192. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu H, Xue Q, Cao W, Yang F, Ma L, Liu W,
Zhang K, Liu X, Zhu Z and Zheng H: Foot-and-mouth disease virus
nonstructural protein 2B interacts with cyclophilin A, modulating
virus replication. FASEB J. June 15–2018.Epub ahead of print.
View Article : Google Scholar
|
|
37
|
Yang D, Yang W, Zhang Q, Hu Y, Bao L and
Damirin A: Migration of gastric cancer cells in response to
lysophosphatidic acid is mediated by LPA receptor 2. Oncol Lett.
5:1048–1052. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Clay MR and Halloran MC: Cadherin 6
promotes neural crest cell detachment via F-actin regulation and
influences active Rho distribution during epithelial-to-mesenchymal
transition. Development. 141:2506–2515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Takahashi K, Fukushima K, Fukushima N,
Honoki K and Tsujiuchi T: Enhanced cellular functions through
induction of LPA2 by cisplatin in fibrosarcoma HT1080
cells. Mol Cell Biochem. 431:29–35. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Takahashi K, Fukushima K, Tanaka K, Minami
K, Ishimoto K, Otagaki S, Fukushima N, Honoki K and Tsujiuchi T:
Involvement of LPA signaling via LPA receptor-2 in the promotion of
malignant properties in osteosarcoma cells. Exp Cell Res.
369:316–324. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang H, Liu W, Wei D, Hu K, Wu X and Yao
Y: Effect of the LPA-mediated CXCL12-CXCR4 axis in the tumor
proliferation, migration and invasion of ovarian cancer cell lines.
Oncol Lett. 7:1581–1585. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Erstad DJ, Tager AM, Hoshida Y and Fuchs
BC: The autotaxinlysophosphatidic acid pathway emerges as a
therapeutic target to prevent liver cancer. Mol Cell Oncol.
4:e13118272017. View Article : Google Scholar
|
|
44
|
Aasrum M, Tjomsland V, Thoresen GH, De
Angelis PM, Christoffersen T and Brusevold IJ: PI3K is required for
both basal and LPA-induced DNA synthesis in oral carcinoma cells. J
Oral Pathol Med. 45:425–432. 2016. View Article : Google Scholar
|
|
45
|
Zeng R, Li B, Huang J, Zhong M, Li L, Duan
C, Zeng S, Huang J, Liu W, Lu J, et al: Lysophosphatidic acid is a
biomarker for peritoneal carcinomatosis of gastric cancer and
correlates with poor prognosis. Genet Test Mol Biomarkers.
21:641–648. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Singla A, Kumar A, Priyamvada S, Tahniyath
M, Saksena S, Gill RK, Alrefai WA and Dudeja PK: LPA stimulates
intestinal DRA gene transcription via LPA2 receptor, PI3K/AKT, and
c-Fos-dependent pathway. Am J Physiol Gastrointest Liver Physiol.
302:G618–G627. 2012. View Article : Google Scholar :
|
|
47
|
Brooks YS, Ostano P, Jo SH, Dai J, Getsios
S, Dziunycz P, Hofbauer GF, Cerveny K, Chiorino G, Lefort K and
Dotto GP: Multifactorial ERβ and NOTCH1 control of squamous
differentiation and cancer. J Clin Invest. 124:2260–2276. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kang L, Mao J, Tao Y, Song B, Ma W, Lu Y,
Zhao L, Li J, Yang B and Li L: MicroRNA-34a suppresses the breast
cancer stem cell-like characteristics by downregulating Notch 1
pathway. Cancer Sci. 106:700–708. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zang MD, Hu L, Fan ZY, Wang HX, Zhu ZL,
Cao S, Wu XY, Li JF, Su LP, Li C, et al: Luteolin suppresses
gastric cancer progression by reversing epithelial-mesenchymal
transition via suppression of the Notch signaling pathway. J Transl
Med. 15:522017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu T, Nie F, Yang X, Wang X, Yuan Y, Lv
Z, Zhou L, Peng R, Ni D, Gu Y, et al: MicroRNA-590 is an
EMT-suppressive microRNA involved in the TGFβ signaling pathway.
Mol Med Rep. 12:7403–7411. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Shao S and Zhao X, Zhang X, Luo M, Zuo X,
Huang S, Wang Y, Gu S and Zhao X: Notch1 signaling regulates the
epithelial-mesenchymal transition and invasion of breast cancer in
a Slug-dependent manner. Mol Cancer. 14:282015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hope JM, Wang FQ, Whyte JS, Ariztia EV,
Abdalla W, Long K and Fishman DA: LPA receptor 2 mediates
LPA-induced endometrial cancer invasion. Gynecol Oncol.
112:215–223. 2009. View Article : Google Scholar
|
|
53
|
Shida D, Kitayama J, Yamaguchi H, Hama K,
Aoki J, Arai H, Yamashita H, Mori K, Sako A, Konishi T, et al: Dual
mode regulation of migration by lysophosphatidic acid in human
gastric cancer cells. Exp Cell Res. 301:168–178. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Suzuki HI, Horie M, Mihira H and Saito A:
Molecular analysis of endothelial-mesenchymal transition induced by
transforming growth factor-β signaling. J Vis Exp. 2018. View Article : Google Scholar
|
|
55
|
Yang M, Zhong WW, Srivastava N, Slavin A,
Yang J, Hoey T and An S: G protein-coupled lysophosphatidic acid
receptors stimulate proliferation of colon cancer cells through the
{beta}-catenin pathway. Proc Natl Acad Sci USA. 102:6027–6032.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yu S, Murph MM, Lu Y, Liu S, Hall HS, Liu
J, Stephens C, Fang X and Mills GB: Lysophosphatidic acid receptors
determine tumorigenicity and aggressiveness of ovarian cancer
cells. J Natl Cancer Inst. 100:1630–1642. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Sun Y, Zhang R, Zhou S and Ji Y:
Overexpression of Notch1 is associated with the progression of
cervical cancer. Oncol Lett. 9:2750–2756. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lin FT and Lai YJ: Regulation of the LPA2
receptor signaling through the carboxyl-terminal tail-mediated
protein-protein interactions. Biochim Biophys Acta. 1781:558–562.
2008. View Article : Google Scholar : PubMed/NCBI
|
